Stay updated on RC48-ADC in HER2+ Biliary Cancer Clinical Trial
Sign up to get notified when there's something new on the RC48-ADC in HER2+ Biliary Cancer Clinical Trial page.

Latest updates to the RC48-ADC in HER2+ Biliary Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 and removed notices including the older v3.4.1; these are minor metadata updates to the study record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check21 days agoChange DetectedA site-wide notice about government funding status appears on the page and the page revision indicator updated from v3.4.0 to v3.4.1. These are system-level updates rather than changes to study content.SummaryDifference0.8%

- Check28 days agoChange DetectedAdded a glossary toggle and color-coded (green for additions, red for deletions) changes to the study history view. The revision label updates to v3.4.0 (replacing v3.3.4) and the No FEAR Act data entry is removed.SummaryDifference1%

- Check42 days agoChange DetectedA new revision entry (v3.3.4) has been added to the study record history, while the previous revision (v3.3.3) was removed. This is an administrative update to the history listing and does not affect study details.SummaryDifference0.1%

- Check49 days agoChange DetectedThe record history adds last known status details (sponsor, date, verification) and a Recruitment Status entry to the study record.SummaryDifference0.9%

- Check63 days agoChange DetectedA new revision entry (v3.3.3) was added to the study record history, and the HHS Vulnerability Disclosure link and the Revision: v3.3.2 entry were removed from the page footer.SummaryDifference0.2%

Stay in the know with updates to RC48-ADC in HER2+ Biliary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RC48-ADC in HER2+ Biliary Cancer Clinical Trial page.